Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | PLA2G2A | P14555 | 3/20 | 0.31 |
| ▸ | PLA2G4A | P47712 | 3/20 | 0.31 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20465307 | 0.97 | KDM4E (0.40) | KDM4EATML3MBTL1MEN1ALDH1A1 | |
| SCHEMBL20070562 | 0.87 | KDM4E (0.37) | KDM4EATML3MBTL1MEN1ALDH1A1 | |
| SCHEMBL17246946 | 0.86 | L3MBTL1 (0.44) | KDM4EATML3MBTL1MEN1ALDH1A1 | |
| SCHEMBL17146755 | 0.85 | L3MBTL1 (0.51) | KDM4EATML3MBTL1MEN1ALDH1A1 | |
| SCHEMBL17146714 | 0.85 | L3MBTL1 (0.51) | KDM4EATML3MBTL1MEN1ALDH1A1 | |
| SCHEMBL17146694 | 0.85 | L3MBTL1 (0.51) | KDM4EATML3MBTL1MEN1ALDH1A1 | |
| SCHEMBL20737604 | 0.85 | MAT2A (0.37) | KDM4EATML3MBTL1MEN1ALDH1A1 | |
| SCHEMBL9889781 | 0.84 | KDM4E (0.45) | KDM4EATML3MBTL1MEN1ALDH1A1 | |
| SCHEMBL19564036 | 0.84 | KDM4E (0.42) | KDM4EATML3MBTL1MEN1ALDH1A1 | |
| SCHEMBL19564041 | 0.84 | KDM4E (0.42) | KDM4EATML3MBTL1MEN1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11512086-B2 | Compound for organic electrical element, organic electrical element using compound, and electronic device therefor | DUK SAN NEOLUX CO., LTD. (KR) | 2022-11-29 | — | — | US | disclosed |
| US-20180222910-A1 | COMPOUND FOR ORGANIC ELECTRICAL ELEMENT, ORGANIC ELECTRICAL ELEMENT USING COMPOUND, AND ELECTRONIC DEVICE THEREFOR | DUK SAN NEOLUX CO., LTD. (KR) | 2018-08-09 | — | — | US | disclosed |
| US-20180222910-A1 | COMPOUND FOR ORGANIC ELECTRICAL ELEMENT, ORGANIC ELECTRICAL ELEMENT USING COMPOUND, AND ELECTRONIC DEVICE THEREFOR | DUK SAN NEOLUX CO., LTD. (KR) | 2018-08-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180222910-A1 | COMPOUND FOR ORGANIC ELECTRICAL ELEMENT, ORGANIC ELECTRICAL ELEMENT USING COMPOUND, AND ELECTRONIC DEVICE THEREFOR | OR51E2, WEE1, SLC39A11 | KDM4E 1762/4885ATM 4000/4885L3MBTL1 511/4885 |
| US-11512086-B2 | Compound for organic electrical element, organic electrical element using compound, and electronic device therefor | OR51E2, WEE1, SLC39A11 | KDM4E 1762/4885ATM 4000/4885L3MBTL1 511/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.